AI assistant
Sending…
PRECIGEN, INC. — Director's Dealing 2019
Jan 9, 2019
32044_dirs_2019-01-08_8777150b-4886-4e14-a72f-262875709b05.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INTREXON CORP (XON)
CIK: 0001356090
Period of Report: 2019-01-04
Reporting Person: Walsh Robert F. III (SVP, Energy & Fine Chem.)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-01-04 | Common Stock | A | 13774 | — | Acquired | 19482 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-01-04 | Restricted Stock Units | $ | A | 75758 | Disposed | Common Stock (75758) | Direct |
Footnotes
F1: These shares of common stock resulted from the grant and immediate vesting of restricted stock units that were issued as a portion of the reporting person's 2018 incentive compensation.
F2: Each restricted stock unit represents a contingent right to receive one share of XON common stock.
F3: The restricted stock units vest in four equal annual installments beginning January 4, 2020.
More from PRECIGEN, INC.
Regulatory Filings
2026
May 13
Annual Report
2026
Apr 30
Director's Dealing
2026
Mar 21
Director's Dealing
2026
Mar 21
Director's Dealing
2026
Mar 21
Director's Dealing
2026
Mar 21
Director's Dealing
2026
Mar 21
Major Shareholding Notification
2026
Feb 13
Major Shareholding Notification
2026
Jan 23
Director's Dealing
2025
Dec 23